AU2134595A - Pharmaceutical preparations and medicinal substances for the prevention and treatment of endothelial dysfunctions - Google Patents
Pharmaceutical preparations and medicinal substances for the prevention and treatment of endothelial dysfunctionsInfo
- Publication number
- AU2134595A AU2134595A AU21345/95A AU2134595A AU2134595A AU 2134595 A AU2134595 A AU 2134595A AU 21345/95 A AU21345/95 A AU 21345/95A AU 2134595 A AU2134595 A AU 2134595A AU 2134595 A AU2134595 A AU 2134595A
- Authority
- AU
- Australia
- Prior art keywords
- prevention
- treatment
- pharmaceutical preparations
- medicinal substances
- endothelial dysfunctions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4410997A DE4410997A1 (en) | 1994-03-30 | 1994-03-30 | Pharmaceutical preparations and drugs for the prevention and treatment of endothelial dysfunctions |
DE4410997 | 1994-03-30 | ||
PCT/DE1995/000421 WO1995026725A1 (en) | 1994-03-30 | 1995-03-28 | Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction |
Publications (3)
Publication Number | Publication Date |
---|---|
AU2134595A true AU2134595A (en) | 1995-10-23 |
AU698359B2 AU698359B2 (en) | 1998-10-29 |
AU698359C AU698359C (en) | 2000-10-19 |
Family
ID=
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7521571B2 (en) | 2003-10-03 | 2009-04-21 | Lacer | Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7521571B2 (en) | 2003-10-03 | 2009-04-21 | Lacer | Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses |
US7777058B2 (en) | 2003-10-03 | 2010-08-17 | Lacer S.A. | Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof |
US8541607B2 (en) | 2003-10-03 | 2013-09-24 | Lacer, S.A. | Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
EE9600139A (en) | 1997-04-15 |
NO964102D0 (en) | 1996-09-27 |
LT4310B (en) | 1998-03-25 |
LV11666B (en) | 1997-06-20 |
FI963883A0 (en) | 1996-09-27 |
LV11666A (en) | 1997-02-20 |
CZ283696A3 (en) | 1998-03-18 |
DE4410997A1 (en) | 1995-10-26 |
HU220165B (en) | 2001-11-28 |
SK121896A3 (en) | 1998-10-07 |
IS4365A (en) | 1996-09-25 |
BG100930A (en) | 1997-07-31 |
PL316528A1 (en) | 1997-01-20 |
CA2186783A1 (en) | 1995-10-12 |
BG63073B1 (en) | 2001-03-30 |
DE19580261D2 (en) | 1997-05-28 |
LT96148A (en) | 1997-12-29 |
MX9604434A (en) | 1997-12-31 |
FI963883A (en) | 1996-09-27 |
WO1995026725A1 (en) | 1995-10-12 |
AU698359B2 (en) | 1998-10-29 |
CN1150387A (en) | 1997-05-21 |
EP0752858A1 (en) | 1997-01-15 |
HUT76676A (en) | 1997-10-28 |
JPH09510979A (en) | 1997-11-04 |
SI9520047A (en) | 1997-06-30 |
NO964102L (en) | 1996-09-27 |
HU9602671D0 (en) | 1996-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2505795A (en) | 1-arylpyrimidine derivatives and pharmaceutical use thereof | |
HU9602671D0 (en) | Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction | |
HU9303282D0 (en) | Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments | |
PL330814A1 (en) | Compounds for and methods of delivering pharmaceutical preparations and their application | |
AU3171997A (en) | Cosmetic and/or pharmaceutical preparations | |
HU9303283D0 (en) | Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments | |
IL127572A (en) | Pharmaceutical composition and medicament for nasal administration | |
AU4204697A (en) | Tetrahydroisoquinoline derivatives and their pharmaceutical use | |
GB9808840D0 (en) | Treatment of depression and pharmaceutical preparations therefor | |
AU7042796A (en) | Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases | |
HUP9602196A2 (en) | Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof | |
AU5103196A (en) | Form of administration for applying pharmaceutical substances and auxiliary substances, and process for the preparation thereof | |
ZA9711129B (en) | New analogues of camptothecin their medical application and the pharmaceutical substances that contain them | |
GB9501286D0 (en) | Pharmaceutical compositions and preparations thereof | |
IL121329A (en) | Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides | |
DE59410107D1 (en) | CHINOXALINE AND MEDICINAL PRODUCTS THEREOF | |
ZA961050B (en) | Substituted benzenesulfonylureas and -thioureas processes for their preparation their use for the production of pharmaceutical preparations and pharmaceutical preparations containing them | |
AU6126398A (en) | Alcoholic treatment and homeopathic pharmaceutical product | |
AU698359C (en) | Pharmaceutical preparations and medicinal substances for the prevention and treatment of endothelial dysfunctions | |
PL312563A1 (en) | Pharmaceutical immunomodulating and treatment aiding preparation | |
ZA951789B (en) | Pharmaceutical materials and methods of administration | |
HUP9602220A2 (en) | Substituted 4h-piranes and pharmaceutical preparations containing them | |
AU7551896A (en) | 1-azabicycloheptane derivatives and their pharmaceutical use | |
GB9302553D0 (en) | Pharmaceutical preparations and their manufacture and use | |
GB9401745D0 (en) | Improvements in and relating to the administration of medicaments or therapeutic substances |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 19990211 |
|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |